Origin & Corporate Overview

Founded in 2005 by a team of senior molecular biologists and bioinformaticians, GenXPro GmbH is a premier German biotechnology company specialising in advanced Next-Generation Sequencing (NGS) applications and high-performance multi-omics analysis. Operating from a specialised laboratory infrastructure in Frankfurt, the company has established itself as a globally trusted partner in genomics, transcriptomics and epigenomics, serving academic institutions, pharmaceutical enterprises and industrial biotechnology clients worldwide.

GenXPro was specifically established to tackle complex challenges in molecular research that standard sequencing approaches fail to address. The company delivers highly tailored end-to-end solutions for demanding projects, ranging from the processing of ultra-low input and highly degraded sample material to the development of innovative sequencing methodologies for both model and non-model organisms, including agricultural plant species. By seamlessly integrating wet-lab expertise with an advanced in-house bioinformatics ecosystem, the company guarantees rapid data turnaround, extensive quality control and smooth integration of cutting-edge multi-omics workflows into existing research pipelines.

Mission & Core Philosophy

The core mission of GenXPro is to democratize specialised NGS expertise and make high-end, sensitive sequencing methodologies universally accessible to laboratories around the globe. By developing advanced library preparation kits and streamlined, robust workflows, the company enables global research facilities to reach unprecedented levels of precision, data sensitivity and operational efficiency.

A primary pillar of this mission is removing technical barriers to data interpretation. Through standardised, automated bioinformatics pipelines, GenXPro empowers researchers and clinicians, regardless of their computational or programming background, to transform complex raw sequence data into deep biological insights. This approach minimises manual processing bottlenecks, eliminates typical bioinformatic friction points and compresses the timeline for data interpretation from weeks to just a few hours.

Vision for Personalised Medicine

Harnessing its deep research foundation and decades of genomic expertise, GenXPro’s long-term vision centers on driving the development of novel biomarkers and highly specific diagnostic panels. This technological evolution aims to pave the way for true personalised medicine, facilitating accurate, reliable and early-stage diagnostics for rare, complex and hard-to-diagnose diseases. By pioneering minimally invasive testing methods, such as ultra-sensitive liquid biopsy applications, GenXPro aims to enhance patient safety and provide clinicians with the accurate molecular data necessary to optimise targeted treatment strategies, ultimately contributing to a future where high-precision healthcare is globally accessible.

Core Product Portfolio

Proprietary NGS Kits
GenXPro develops and distributes proprietary RNA sequencing kits globally, powered by its pioneering TrueQuant (TQ) technology, historically vital to the development of Molecular Barcoding and Unique Molecular Identifiers (UMIs). All kits share exceptional sensitivity, capable of handling sample inputs as low as 10 pg and are engineered for highly degraded material like FFPE tissue and liquid biopsies.

• TQ MACE-Seq: High-efficiency 3’mRNA-Seq optimised for cost-effective, digital gene expression profiling and biomarker identification.
• TQ small RNA-Seq: A highly specialised kit dedicated exclusively to the targeted capture and analysis of small non-coding RNA species, providing precise quantification without amplification biases.
• TQ pan-RNA-Seq: An innovative workflow designed for the simultaneous analysis of small RNAs and mRNAs from a single sample, maximising data output from limited material.

End-to-End Services & BioInfonomics
Clients can leverage a full contract research workflow by submitting native tissue, isolated RNA or DNA.

• Multi-Omics Services: Expert execution of ATAC-Seq, CAGE-Seq, tRNA-Seq, WES, Methyl-Seq, Ribo-Seq and Degradome-Seq.
• GXP BioInfonomics Suite: An automated cloud platform where users upload raw Illumina or FastQ data. Standardised pipelines execute mapping, mutation profiling, variant calling and pathway analyses (GSEA), delivering comprehensive, actionable clinical reports within minutes to hours.

Global Access & Evaluation

• Request a Trial: Researchers and laboratory managers looking to streamline their data pipeline can request complimentary trial access to the automated GXP BioInfonomics Suite via the company’s registration portal.
• Evaluation Kits: Validation kits for TrueQuant-powered RNA sequencing applications are available upon inquiry to support workflow evaluation in local laboratory settings.

Corporate Directory & Contact Details

• Company Name: GenXPro GmbH
• Headquarters: Altenhöferallee 3, 60438 Frankfurt am Main, Germany
• Founded: 2005
• Core Sector: Biotechnology / Next-Generation Sequencing (NGS) & Bioinformatics
• Official Website: www.genxpro.net
• General & Media Inquiries: info@genxpro.de
• Technical Support & Service Requests: support@genxpro.de

---